Serotonin 2A-1438 G/A and G-protein beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects

被引:75
作者
Bishop, Jeffrey R.
Moline, Jessica
Ellingrod, Vicki L.
Schultz, Susan K.
Clayton, Anita H.
机构
[1] Univ Iowa, Coll Pharm, Clin & Adm Div, Iowa City, IA 52242 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL USA
[3] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA USA
[4] Univ Virginia, Sch Med, Dept Psychiat Med, Charlottesville, VA 22908 USA
关键词
sexual side-effects; SSRI; depression; serotonin 2A receptor; G-protein beta subunit; pharmacogenetics;
D O I
10.1038/sj.npp.1301090
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The occurrence of sexual side-effects from antidepressants is thought to be mediated through serotonin 2A (5HT2A) receptors. It is currently unknown if functional polymorphisms in the 5HT2A receptor or its G-protein second messenger complex are related to sexual dysfunction in patients taking an selective serotonin reuptake inhibitor (SSRI) for depression. The purpose of this study was to determine the relationship of the 5HT2A-1438 G/A and GNB3 C825T single nucleotide polymorphisms with overall sexual well-being and individual components of sexual health as measured by the Changes in Sexual Functioning Questionnaire (CSFQ). We evaluated 89 outpatients (18-40 years of age) at low risk for other causes of sexual dysfunction who were being treated for depression with an SSRI and did not have sexual difficulties before taking the antidepressant. Outcome measures were stratified by 5HT2A and GNB3 genotypes. After controlling for age, gender, anxiety scale scores, and depression scale scores, persons with a GG genotype of the 5HT2A-1438 single nucleotide polymorphisms (SNP) were significantly more likely to be categorized as having sexual dysfunction than persons with a GA or AA genotype (OR = 3.6; 95% CI 1.03, 12.6; p = 0.046). Furthermore, the 5HT2A-1438 GG genotype was a significant predictor of lower arousal scores (p = 0.022) after accounting for other measures. There was no significant relationship between any outcome measure and GNB3 genotype.
引用
收藏
页码:2281 / 2288
页数:8
相关论文
共 34 条
[1]   CYPROHEPTADINE TREATMENT OF SEXUAL DYSFUNCTION INDUCED BY SEROTONIN REUPTAKE INHIBITORS [J].
AIZENBERG, D ;
ZEMISHLANY, Z ;
WEIZMAN, A .
CLINICAL NEUROPHARMACOLOGY, 1995, 18 (04) :320-324
[2]   Mianserin, a 5-HT2a/2c and alpha(2) antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors [J].
Aizenberg, D ;
Gur, S ;
Zemishlany, Z ;
Granek, M ;
Jeczmien, P ;
Weizman, A .
CLINICAL NEUROPHARMACOLOGY, 1997, 20 (03) :210-214
[3]   Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine [J].
Arranz, MJ ;
Munro, J ;
Owen, MJ ;
Spurlock, G ;
Sham, PC ;
Zhao, J ;
Kirov, G ;
Collier, DA ;
Kerwin, RW .
MOLECULAR PSYCHIATRY, 1998, 3 (01) :61-66
[4]   Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction [J].
Ashton, AK ;
Rosen, RC .
JOURNAL OF SEX & MARITAL THERAPY, 1998, 24 (03) :191-192
[5]   PHARMACOLOGICAL ANALYSIS OF MALE-RAT SEXUAL-BEHAVIOR [J].
BITRAN, D ;
HULL, EM .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1987, 11 (04) :365-389
[6]   Identification of genetic variants in the neuronal form of tryptophan hydroxylase (TPH2) [J].
Breidenthal, SE ;
White, DJ ;
Glatt, CE .
PSYCHIATRIC GENETICS, 2004, 14 (02) :69-72
[7]   Discontinuing or switching selective serotonin-reuptake inhibitors [J].
Bull, SA ;
Hunkeler, EM ;
Lee, JY ;
Rowland, CR ;
Williamson, TE ;
Schwab, JR ;
Hurt, SW .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (04) :578-584
[8]  
CLAYTON AH, 1995, PSYCHOPHARMACOL BULL, V31, P397
[9]   Prevalence of sexual dysfunction among newer antidepressants [J].
Clayton, AH ;
Pradko, JF ;
Croft, HA ;
Montano, CB ;
Leadbetter, RA ;
Bolden-Watson, C ;
Bass, KI ;
Donahue, RMJ ;
Jamerson, BD ;
Metz, A .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (04) :357-366
[10]  
Clayton AH, 1997, PSYCHOPHARMACOL BULL, V33, P731